about
Azathioprine-induced Acute Pancreatitis in Patients with Inflammatory Bowel Diseases--A Prospective Study on Incidence and SeverityLong-term safety and efficacy of budesonide in the treatment of ulcerative colitisp38 Mitogen activated protein kinase (MAPK): a new therapeutic target for reducing the risk of adverse pregnancy outcomes.Regulatory framework on bioequivalence criteria for locally acting gastrointestinal drugs: the case for oral modified release mesalamine formulations.MMX® technology and its applications in gastrointestinal diseases.FK506-Binding Protein 5 mRNA Levels in Ileal Mucosa Are Associated with Pouchitis in Patients with Ulcerative Colitis.
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Therapeutic benefits of budesonide in gastroenterology
@ast
Therapeutic benefits of budesonide in gastroenterology
@en
Therapeutic benefits of budesonide in gastroenterology
@nl
type
label
Therapeutic benefits of budesonide in gastroenterology
@ast
Therapeutic benefits of budesonide in gastroenterology
@en
Therapeutic benefits of budesonide in gastroenterology
@nl
prefLabel
Therapeutic benefits of budesonide in gastroenterology
@ast
Therapeutic benefits of budesonide in gastroenterology
@en
Therapeutic benefits of budesonide in gastroenterology
@nl
P2860
P356
P1476
Therapeutic benefits of budesonide in gastroenterology
@en
P2093
Colm A O'Morain
Sarah O'Donnell
P2860
P304
P356
10.1177/2040622310379293
P407
P577
2010-07-01T00:00:00Z